“This is not Theranos 2.0,” the post reads. “Theranos attempted to miniaturize existing tests. Our approach is fundamentally different. We use light to read the complete molecular story in biological fluids, seeing patterns current tests can’t detect. Not an improvement. A different paradigm.”

See guys, they came up with a totally different idea for this one. It’s all about molecular stories now.